Search Results

You are looking at 51 - 60 of 1,072 items for :

  • "community" x
  • Refine by Access: All x
Clear All
Full access

CLO23-032: Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting

Dariusz Uczkowski, Arunabh Sekhri, Shilpi Gupta, Leah Gendler, Krzysztof Misiukiewicz, Miles Levin, and Bonni Guerin

. Conclusion: In a community hospital setting, retained HER2 positivity on RD after NAC was associated with a statistically worse RFS. Although, small sample size and short follow-up time likely contributed to this outcome and further prospective investigation

Full access

HSR21-070: Feasibility of Tracking Digital Activity, Sleep, and Patient-Reported Outcomes (PROs) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Undergoing an In-Class Transition From Parenteral Bortezomib-Based Therapy to Oral Ixazomib-Lenalidomide-Dexamethasone (IRd) in the Ongoing Community-Based United States (US) MM-6 Study (NCT03173092)

Kirsten Stuber, Habte A. Yimer, Karin Choquette, Sudhir Manda, Jennifer Clayton, Saulius Girnius, Joshua Richter, Presley Whidden, Kimberly Bogard, Dasha Cherepanov, and Stephen J. Noga

Background: US MM-6 is evaluating in-class transition from parenteral bortezomib-based induction to all-oral IRd in US community NDMM pts, with the aim of increasing proteasome-inhibitor-based treatment duration while maintaining quality of life

Full access

Guiding Lay Navigation in Geriatric Patients With Cancer Using a Distress Assessment Tool

Gabrielle B. Rocque, Richard A. Taylor, Aras Acemgil, Xuelin Li, Maria Pisu, Kelly Kenzik, Bradford E. Jackson, Karina I. Halilova, Wendy Demark-Wahnefried, Karen Meneses, Yufeng Li, Michelle Y. Martin, Carol Chambless, Nedra Lisovicz, Mona Fouad, Edward E. Partridge, Elizabeth A. Kvale, and the Patient Care Connect Group

on screening of geriatric patients in rural, community settings. In addition, the sources of distress for this patient population have not been characterized. Patient navigators may be able to both screen for and mitigate sources of distress for

Full access

Improving Health Equity and Reducing Disparities in Pediatric and Adolescent/Young Adult Oncology: In Support of Clinical Practice Guidelines

Justine M. Kahn and Melissa Beauchemin

categorized as economic, education, social and community context, neighborhood, and the built environment. They include upstream factors such as political, socioeconomic, and cultural constructs, as well as place-based factors such as access to healthcare

Full access

QIM20-124: Retrospective Evaluation of VEGF Inhibitor-Associated Hypertension at a Community Cancer Center

Jasmin Eugene, Carli Nesheiwat, and Scott Overmier

Full access

CLO19-058: Live Music to Decrease Patient Anxiety During Chemotherapy Treatments

Crystal Weaver, Mark Varvares, Elaine Ottenlips, Kara Christopher, and Andrew Dwiggins

Background: Music therapy began in the United States after World War II when community musicians went to veterans’ hospitals to provide live music to those experiencing post-war trauma. Music therapy programs continue to utilize community musicians

Full access

QIM24-192: Place of Death From Cancer in Episodic Value Based Care Models in a Community Oncology Network

Puneeth Indurlal, Lalan Wilfong, Sharon Hart, Hope Ives, and Jessica Neeb

Full access

Influence of Treating Facility, Provider Volume, and Patient-Sharing on Survival of Patients With Multiple Myeloma

Ashley T. Freeman, May Kuo, Lei Zhou, Justin G. Trogdon, Chris D. Baggett, Sascha A. Tuchman, Thomas C. Shea, and William A. Wood

volume on patient outcomes may help inform referral practices. A common practice is to refer patients to an MM specialist for treatment recommendations, but to perform most care in the community. The impact on survival of patient-sharing among MM

Full access

HSR19-097: Understanding U.S. Mutational Testing Patterns and Treatment Implications in Gastrointestinal Stromal Tumors (GIST) Patients

Khalid Mamlouk, Zach Crouch, Philina Lee, Clive Mendonca, Maria Gumina, and Brian Rubin

treaters further examines mutational testing and treatment decisions to better understand current practices and educational needs. Methods: Hematologist/oncologists who practiced in academic or community settings were eligible if they treated ≥5 pts with

Full access

HSR23-117: First-Line (1L) Systemic Therapy in Patients (pts) With Advanced Non–Small Cell Lung Cancer (aNSCLC) at Community Settings in the United States (US)

Stephen Liu, Pragya Rai, Yu-Han Kao, Diana Chirovsky, and Ana Nunes